Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: A report from the children's oncology group-Reference-Cited by-同舟云学术

Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: A report from the children's oncology group

Published:2014-11-18 Issue:3 Volume:62 Page:414-418
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Salzer Wanda L.¹,Jones Tamekia L.²,Devidas Meenakshi²,Dreyer ZoAnn E.³,Gore Lia⁴,Winick Naomi J.⁵,Sung Lillian⁶,Raetz Elizabeth⁷,Loh Mignon L.⁸,Wang Cindy Y.⁹,De Lorenzo Paola¹⁰¹¹,Valsecchi Maria Grazia¹¹,Pieters Rob¹²,Carroll William L.¹³,Hunger Stephen P.⁴,Hilden Joanne M.⁴,Brown Patrick¹⁴

Affiliation:

1. U.S. Army Medical Research and Materiel Command; Fort Detrick Maryland

2. Department of Biostatistics; Colleges of Medicine and Public Health & Health Professions; University of Florida; Gainesville Florida

3. Texas Children's Cancer Center; Baylor College of Medicine; Houston Texas

4. Childrens Hospital Colorado; University of Colorado School of Medicine; Aurora Colorado

5. Division of Pediatric Hematology/Oncology; University of Texas Southwestern School of Medicine; Dallas Texas

6. Division of Haematology/Oncology; The Hospital for Sick Children; Toronto Ontario Canada

7. Department of Pediatrics and Huntsman Cancer Institute; University of Utah; Salt Lake City Utah

8. Department of Pediatrics; University of California; San Francisco California

9. Children's Oncology Group Statistics and Data Center University of Florida; Gainesville; Florida

10. Interfant Trial Data Center; Pediatric Clinic; University of Milano-Bicocca; Monza Italy

11. Department of Health Sciences; University of Milano Bicocca; Monza Italy

12. Princess Maxima Center for Pediatric Oncology; Utrecht; Pediatric Oncology; Erasmus MC - Sophia Children's Hospital; Rotterdam Netherlands

13. New York University Cancer Institute; New York; New York

14. Oncology and Pediatrics; Johns Hopkins University; Baltimore Maryland

Funder

National Institutes of Health

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.25311/fullpdf

Reference25 articles.

1. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000;Moricke;Leukemia,2010

2. Treating childhood acute lymphoblastic leukemia without cranial irradiation;Pui;N Engl J Med,2009

3. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: A report from the children's oncology group;Hunger;J Clin Oncol,2012

4. Comparison of high-dose methotrexate (HD-MTX) with Capizzi methotrexate plus asparaginase (C-MTX/ASNase) in children and young adults with high-risk acute lymphoblastic leukemia (HR-ALL): A report from the Children's Oncology Group Study AALL0232;Larsen;ASCO Meeting Abstracts,2011

5. Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group;Seibel;Blood,2008

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution and optimization of therapies for acute lymphoblastic leukemia in infants;International Journal of Hematology;2022-11-28

2. Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group;The Lancet Haematology;2022-09

3. Outstanding outcomes in infants with <i>KMT2A</i>-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children’s Oncology Group AALL0631 trial;Haematologica;2022-02-17

4. Allogeneic hematopoietic stem cell transplantation in infants is associated with significant morbidity and mortality;Pediatric Transplantation;2022-02-05

5. Acute Lymphoblastic Leukemia in Infants: A Distinctive, High-Risk Subtype of Childhood Acute Lymphoblastic Leukemia;Clinical Management of Acute Lymphoblastic Leukemia;2022